Clinical Usefulness of Plasma Androstanediol Glucuronide Measurements in Women with Idiopathic Hirsutism
October 1987
in “
The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism
”
New to Spironolactone? There is a guide in the encyclopedia. Read the guide → Studysummary This study found that serum 3 alpha-diol G levels in women with idiopathic hirsutism correlated well with their clinical response to treatment, suggesting its usefulness in evaluating treatment outcomes.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
In a study from 1987, serum androstanediol glucuronide (3 alpha-diol G) levels were found to be significantly elevated in 28 women with idiopathic hirsutism (IH), with a mean level of 487 +/- 192 ng/dL, compared to 119 +/- 37 ng/dL in a control group of 50 normal women. The study also followed 17 women with IH during treatment with glucocorticoids, contraceptives, or spironolactone for 1-4 years and found that changes in serum 3 alpha-diol G levels were consistent with clinical responses in 15 of these patients. This was in contrast to the poor concordance with serum testosterone, free testosterone, and androstenedione levels. Additionally, in patients treated with spironolactone, clinical improvement was often seen without significant changes in testosterone levels, but with corresponding decreases in 3 alpha-diol G levels. The study concluded that serum 3 alpha-diol G measurements are clinically useful for evaluating and monitoring treatment response in women with hirsutism.
